Trial Profile
A study evaluating efficacy and safety of etanercept in patients with moderate-to-severe plaque psoriasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Aug 2017 New trial record
- 03 Aug 2017 Results of pooled analysis of 10 trials (NCT00245960, NCT00111449, NCT00663052, NCT00454584) generating evidence concerning the number of patients dropping out of etanercept trials published in the British Journal of Dermatology
- 31 Jul 2008 Results published in the British Journal of Dermatology